bcl-2 protein downregulation is not required for differentiation of multidrug resistant HL60 leukemia cells

Leukemia Research

Volumn 20, Issue 2, 1996, Pages 101-107

  Blagosklonny, Mikhail V ^a,b   Alvarez, Manuel ^a   Fojo, Antonio ^a   Neckers, Leonard M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

bax; bcl 2; Differentiation; Drug resistance; Leukemia; p21 Waf1; Phorbol ester

Indexed keywords

MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOSTASIS; DOWN REGULATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0029968299     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00103-4     Document Type: Article

References (26)

1. Korsmeyer S. J. (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80, 879.
2. Reed J. C. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 124, 1.
3. Gunji H., Hass R. & Kufe D. (1992) Internucleosomal DNA fragmentation during phorbol ester-induced monocytic differentiation and G0/G1 arrest. J. Clin. Invest. 89, 954.
4. Delia D., Aiello A., Soligo D., Fontanella E., Melani C., Pezzella F., Pierotti M. A. & Porta G. D. (1992) Bcl-s2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79, 1291.
5. Xu H. M., Tepper C. G., Jones J. B., Fernandez C. E. & Studzinski G. P. (1993) 1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Expl Cell. Res. 209, 367.
6. Park J. R., Robertson K., Hickstein D. D., Tsai S., Hockenbery D. M. & Collins S. J. (1994) Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood 84, 440.
7. Naumovski L. & Cleary M. L. (1994) Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 83, 2261.
8. Smith M. R., Al-Katib A., Mohammad R., Silverman A., Szabo P., Khilnani S., Kohler W., Nath R. & Mutchnick M. G. (1993) Prothymosin alpha gene expression correlates with proliferation, not differentiation, of HL-60 cells. Blood 82, 1127.
9. Boise L. H., Gonzaiz-Garcia M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao X., Nunez G. & Thompson C. B. (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597.
10. Oltvai Z. N., Milliman C. L. & Korsmeyer S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609.
11. Korsmeyer S. J., Shutter J. R., Veis D. J., Merry D. E. & Oltvai Z. N. (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4, 327.
12. Miyashita T., Krajewski S., Krajewska M., Wang H. G., Lin H. K., Liebermann D. A., Hoffman B. & Reed J. C. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799.
13. Wolf D. & Rotter V. (1985) Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc. natn. Acad. Sci. USA 82, 790.
14. El-Deiry W. S., Tokino T., Veculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W. & Vogelstein B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817.
15. El-Deiry W. S., Harper J. W., O'Connor P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y., Wiman K. G., Mercer W. E., Kastan M. B., Kohn K. W., Elledge S. J., Kinzler K. W. & Vogelstein B. (1994) WAF1/CIP1 is induced in p53 mediated G1 arrest and apoptosis. Cancer Res. 54, 1169.
16. Jiang H., Lin J., Su Z., Collart F. R., Huberman E. & Fisher P. B. (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9, 3397.
17. Steinman R. A., Hoffman B., Iro A., Guillouf C., Liebermann D. A. & El-Houseini M. E. (1994) Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9, 3389.
18. Zhang W., Grasso L., McClain C. D., Gambel A. M., Cha Y., Travali S., Deisseroth A. B. & Mercer W. E. (1995) p53-Independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 55, 668.
19. Aquino A., Hartman K. D., Knode M. C., Grant S., Huang K.-P., Niu C.-H. & Glazer R. I. (1988) Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells. Cancer Res. 48, 3324.
20. Rohlff C., Safa B., Rahman A., Cho-Chung Y. S., Klecker R. W. & Glazer R. I. (1993) Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type 1 cyclic AMP dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities. Mol. Pharmacol. 43, 372.
21. Hickstein D. D., Smith A. J., Fisher W., Beatty P., Schwartz B. R., Harlan J. M., Root R. K. & Locksley R. M. (1987) Expression of leukocyte adherence related glycoproteins during differentiation of HL-60 promyelocytic leukemia cells. J. Immunol. 141, 4313.
22. Blagosklonny M. V. & Neckers L. M. (1994) Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines. Cancer Lett. 76, 81.
23. Whitesell L., Mimnaugh E. G., De Costa B., Myers C. E. & Neckers L. M. (1994) Inhibition of HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. PNAS 91, 8324.
24. Murphy L. D., Herzog C. E., Rudick J. B., Fojo A. T. & Bates S. E. (1990) Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry 29, 10351.
25. Kitada S., Takayama S., De Riel K., Tanaka S. & Reed J. C. (1994) Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Res. Dev. 4, 71.
26. Iwai K., Miyawaki T., Takizawa T., Konno A., Ohta K., Yachie A., Seki H. & Taniguchi N. (1994) Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84, 1201.